Study of the Choroidal and Retinal Thickness in Relation to Axial Length.
NCT ID: NCT03377075
Last Updated: 2019-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2017-02-06
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Choroidal Thickness Using Optical Coherence Tomography
NCT06272851
Objective Choroidal Thickness Measurements in Uveitis
NCT03889860
Semi-manual Vessel Density Analysis on Optical Coherence Tomography Angiography Images of Healthy Adults
NCT03590899
Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion
NCT03357146
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
With optical coherence tomography (OCT) non-invasive and non-contact measurement of the choroidal and retinal thickness is possible. Swept-source OCT is one the latest developments of OCTs. Its increase wavelength allows deeper penetration than previous models and allows high resolution imaging.
OCTs are FDA approved machines, they are not considered experimental. The swept-source OCT machine (DRI OCT-1 Model Triton (plus), Topcon, Tokyo, Japan) used in the study is a CE marked commercially available medical device.
The goal of the study is to evaluate the choroidal and the retinal morphology in relation to the length of the eyeball (axial length - AL) in healthy, young adults.
There are several publications on this topic, most of them on asian populations.
In the study healthy, Caucasians in their twenties are recruited to minimize the aging effect on choroidal thickness.
Following informed consent, demographics are recorded, refraction is taken, axial length is measured with IOL Master 500 (Carl Zeiss AG, Germany) then OCT is performed.
Pupil dilation is not necessary. Images are stored digitally by abiding corresponding laws on personal data protection. Results are processed with statistical analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy subjects
AL measurement
IOL Master 500 (Carl Zeiss AG, Germany)
OCT
Choroidal and retinal thickness measurement (DRI OCT-1 Model Triton (plus), Topcon, Tokyo, Japan)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AL measurement
IOL Master 500 (Carl Zeiss AG, Germany)
OCT
Choroidal and retinal thickness measurement (DRI OCT-1 Model Triton (plus), Topcon, Tokyo, Japan)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caucasian race
* Signed informed consent
Exclusion Criteria
* Inability to act
* Media opacity in the eye that would disturb imaging
18 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Semmelweis University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miklos Schneider MD, PhD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miklos Schneider
Role: PRINCIPAL_INVESTIGATOR
Semmelweis University, Department of Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Semmelweis University, Department of Ophthalmology
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHORAL-1249
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.